Drug Type siRNA |
Synonyms SRSD 216, SRSD216 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lipoprotein (a) hyperlipoproteinemia | IND Approval | China | 20 Mar 2025 | |
Cardiovascular Diseases | IND Application | China | 19 Oct 2023 |